News & Updates

Show Multimedia Only

High, low intakes of dietary iron linked to gastric cancer risk

25 Feb 2026

Dietary iron intake appears to have a U-shaped association with the risk of gastric cancer, as suggested in a case–control study.

High, low intakes of dietary iron linked to gastric cancer risk

25 Feb 2026

Biologic + behavioural therapy shows favourable signals in CATHARSIS trial

24 Feb 2026 by

A novel therapeutic approach combining behavioural and biologic treatments appears feasible for the management of individuals with Crohn’s disease, based on feasibility and early outcomes from the CATHARSIS* trial.

Biologic + behavioural therapy shows favourable signals in CATHARSIS trial

24 Feb 2026

Chronic liver disease ups risk of post-ERCP complications

23 Feb 2026

Endoscopic retrograde cholangiopancreatography (ERCP), although deemed safe, is associated with the highest risk of complications when compared with other endoscopic procedures, reveals a study.

Chronic liver disease ups risk of post-ERCP complications

23 Feb 2026

Young at gut: How to modulate the microbiome for healthy ageing?

23 Feb 2026 by

At the Microbiome Summit 2026, experts shared insights into how the gut microbiome can be modulated to support healthy ageing.

Young at gut: How to modulate the microbiome for healthy ageing?

23 Feb 2026

Should IBD patients avoid prescription NSAIDs?

19 Feb 2026 by

Despite the reported adverse effects of nonsteroidal anti-inflammatory drugs (NSAIDs) in individuals with inflammatory bowel disease (IBD), a study presented at Crohn’s and Colitis Congress 2026 appears to show otherwise.

Should IBD patients avoid prescription NSAIDs?

19 Feb 2026

Ultraprocessed foods are the new cigarettes: study

17 Feb 2026 by

Ultraprocessed foods (UPFs) are associated with several preventable diseases and must be viewed not only through a nutritional lens but also as addictive, industrially engineered substances, which can be likened to cigarettes, suggests a recent study.

Ultraprocessed foods are the new cigarettes: study

17 Feb 2026

Upadacitinib stays effective for 1 year in real-world UC patients

16 Feb 2026 by

Treatment with upadacitinib appears to yield high and durable remission rates in patients with ulcerative colitis (UC), according to 1-year data from a real-world study.

Upadacitinib stays effective for 1 year in real-world UC patients

16 Feb 2026

Original New Drug Application Approvals by US FDA (1-15 February 2026)

16 Feb 2026

New drug applications approved by US FDA as of 1-15 February 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 February 2026)

16 Feb 2026

GLP-1 RAs bring a number of benefits in IBD

15 Feb 2026 by

The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) among patients with inflammatory bowel disease (IBD) appears to result in favourable clinical outcomes, as shown in two retrospective studies.

GLP-1 RAs bring a number of benefits in IBD

15 Feb 2026

Advanced therapy has no impact on time to pregnancy in women with IBD

14 Feb 2026 by

Exposure to advanced therapies, including biologics and small molecules, within 3 months of conception is not associated with an increase in time to pregnancy among women with inflammatory bowel disease (IBD), according to the WIsDoM* trial presented at the Crohn’s and Colitis Congress 2026.

Advanced therapy has no impact on time to pregnancy in women with IBD

14 Feb 2026

News & Updates

Showing Gastroenterology articles

Showing

Specialty:

High, low intakes of dietary iron linked to gastric cancer risk

High, low intakes of dietary iron linked to gastric cancer risk

Biologic + behavioural therapy shows favourable signals in CATHARSIS trial

Biologic + behavioural therapy shows favourable signals in CATHARSIS trial

Chronic liver disease ups risk of post-ERCP complications

Chronic liver disease ups risk of post-ERCP complications

Young at gut: How to modulate the microbiome for healthy ageing?

Young at gut: How to modulate the microbiome for healthy ageing?

Should IBD patients avoid prescription NSAIDs?

Should IBD patients avoid prescription NSAIDs?

Ultraprocessed foods are the new cigarettes: study

Ultraprocessed foods are the new cigarettes: study

Upadacitinib stays effective for 1 year in real-world UC patients

Upadacitinib stays effective for 1 year in real-world UC patients

Original New Drug Application Approvals by US FDA (1-15 February 2026)

Original New Drug Application Approvals by US FDA (1-15 February 2026)

GLP-1 RAs bring a number of benefits in IBD

GLP-1 RAs bring a number of benefits in IBD

Advanced therapy has no impact on time to pregnancy in women with IBD

Advanced therapy has no impact on time to pregnancy in women with IBD